A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Clinical trial NCT05230186 · UNKNOWN
Trial details
- NCT number
- NCT05230186
- Sponsor
- TScan Therapeutics, Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-26
- Primary completion
- 2024-12-23
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.